PRJNA682322
Microbiome profile and molecular pathways alterations in gastrointestinal tract by hydrogen sulfide-releasing non-steroidal anti-inflammatory drug (ATB-352).
This study aims to evaluate the possible alterations in intestinal microbiome profile in rats treated i.g. for 7 days with vehicle, ketoprofen and hydrogen sulfide-releasing ketoprofen (ATB-352).